Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia (Q74225875)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

N Müller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Empl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Riedel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Schwarz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Ackenheil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

European Archives of Psychiatry and Clinical Neuroscience

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

308-313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02922260

9 November 2019

exact match

0 references

cites work

Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients

1 reference

12 December 2020

A comprehensive macrophage-T-lymphocyte theory of schizophrenia

1 reference

12 December 2020

Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values

1 reference

12 December 2020

Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects

1 reference

12 December 2020

Effect of antitumor surgery on soluble interleukin-2 receptor serum levels

1 reference

12 December 2020

Cytokine production in drug-free and neuroleptic-treated schizophrenic patients

1 reference

12 December 2020

Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs

1 reference

12 December 2020

Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes?

1 reference

12 December 2020

Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms

1 reference

12 December 2020

Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology

1 reference

12 December 2020

IL-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants

1 reference

12 December 2020

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness

1 reference

12 December 2020

Increased serum soluble interleukin-2 receptors in Caucasian and Korean schizophrenic patients

1 reference

12 December 2020

Hepatitis B vaccination in psychiatric patients

1 reference

12 December 2020

Haloperidol and soluble interleukin-2 receptors

1 reference

12 December 2020

Analysis of regulation of T-cell responses by soluble inhibitory factors from the sera of patients with Hodgkin's disease

1 reference

12 December 2020

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

1 reference

12 December 2020

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

1 reference

12 December 2020

Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors

1 reference

12 December 2020

PHENOTHIAZINE EFFECT ON HUMAN ANTIBODY SYNTHESIS

1 reference

12 December 2020

Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins

1 reference

12 December 2020

Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine

1 reference

12 December 2020

[Role of the cytokine network in the CNS and psychiatric disorders]

1 reference

12 December 2020

Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients

1 reference

12 December 2020

Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia

1 reference

12 December 2020

Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes

1 reference

12 December 2020

Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system.

1 reference

12 December 2020

Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives

1 reference

12 December 2020

Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients

1 reference

12 December 2020

Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins

1 reference

12 December 2020

TNF alpha induces IL-6 production by astrocytes but not by microglia.

1 reference

12 December 2020

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

1 reference

12 December 2020

Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo.

1 reference

12 December 2020

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

1 reference

12 December 2020

Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients

1 reference

12 December 2020

The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness

1 reference

12 December 2020

Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures

1 reference

12 December 2020

Interleukin-2 does not cross the blood-brain barrier by a saturable transport system.

1 reference

12 December 2020

Elevated levels of soluble interleukin 2 receptors in schizophrenia

1 reference

12 December 2020

Interleukin-2 modulates calcium currents in dissociated hippocampal CA1 neurons.

1 reference

12 December 2020

Effect of psychotropic agents upon the blastogenic response of human t-lymphocytes

1 reference

12 December 2020

Immunoregulators in the nervous system

1 reference

12 December 2020

Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production

1 reference

12 December 2020

The interleukins-1 alpha, -1 beta, and -2 do not acutely disrupt the murine blood-brain barrier

1 reference

12 December 2020

Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis

1 reference

12 December 2020

Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients.

1 reference

12 December 2020

Cellular immunity in schizophrenic patients before and during neuroleptic treatment

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02922260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9477010%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 November 2019

0 references

1 reference